Keywords: antisoma, find, funds, reap, benefits, pemtumomab, uk

Antisoma needs to find funds to reap benefits from pemtumomab

Article | 14 January 2002

Print This

Antisoma of the UK says that amendments have been made to its existinglicensing deal with US drug major Abbott Laboratories ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in